Blog
- All
- News
Shivom Releases Updated Marketplace, Enabling OMX Token Payment via MetaMask
Shivom releases ‘Shop 1.5’ which provides consumers with unique incentives and the ability to purchase direct-to-consumer genetic testing products either by OMX token or fiat payment. London, United Kingdom – May 23, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, …
Continue reading “Shivom Releases Updated Marketplace, Enabling OMX Token Payment via MetaMask”
- All
- News
Shivom Releases Updated Marketplace, Enabling OMX Token Payment via MetaMask
Shivom releases ‘Shop 1.5’ which provides consumers with unique incentives and the ability to purchase direct-to-consumer genetic testing products either by OMX token or fiat payment. London, United Kingdom – May 23, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, …
Continue reading “Shivom Releases Updated Marketplace, Enabling OMX Token Payment via MetaMask”
Here’s How Shivom Chooses it’s Marketplace Partners
This week, Shivom will launch its first iteration of our direct-to-consumer health management marketplace. In this post, we will be providing information to the community and prospective partners about how we determine which products and companies are listed on our platform. Shivom’s mission is to not only optimize how DNA is shared, secured and analysed …
Continue reading “Here’s How Shivom Chooses it’s Marketplace Partners”
Shivom Adds Chronomics to the Marketplace, Offering Customers Epigenetic Testing with OMX Token Payment
Chronomics EpiPlanner Epigenetic Test will provide Shivom’s customers with lifestyle and environment indicators to reveal an overall picture of your health. London, United Kingdom – May 20, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has teamed up with Chronomics, …
- Item Type
- Blog
- Community
- Health Topic
- News
- Product
It’s time to take ownership
Blockchain can help you control, protect and share your health data — helping you and others live healthier, longer lives Exciting advances in precision medicine over the past decade should mean you and your family are now receiving advanced levels of healthcare and disease prevention based on your genetic makeup. Researchers and health professionals across …
Breast Cancer Awareness Month: A Look at the BRCA Gene
As October is the month of Breast Cancer Awareness, we thought it a good idea to examine the BRCA genes in more detail, given our area of focus. In case you missed it, Shivom recently announced its partnership with Genetic Technologies Limited, in the aim of improving the methods for predicting the presence of cancer (and subsequently …
Continue reading “Breast Cancer Awareness Month: A Look at the BRCA Gene”
Shivom Announces Token Buyback Plans for 2019
Shivom is pleased to announce its plans to buyback up to 30 million OMX tokens or approximately 5% of current circulating supply in preparation for Shivom’s beta platform release plans in 2019. Beyond simply removing some OMX from current market conditions, Shivom plans to allocate the repurchased OMX tokens exclusively for incentivization early adopters and …
Continue reading “Shivom Announces Token Buyback Plans for 2019”
World Alzheimer’s Awareness Month
Shivom is helping to make diseases like Alzheimer’s a thing of the past. By creating a secure platform for the storage and sharing of genomic data, Shivom is transforming the precision medicine of tomorrow by allowing researchers and pharmaceutical R&D pipelines access to vital genomic data today. This type of data can help determine an …
Our Alpha Public Release!
Back in August, we announced that we would be releasing a platform in order for our community to test and give us feedback on the first iteration of our Alpha product. After onboarding a wealth of new talent and welcoming Henry Ines to the role of CEO, we felt it time to take a step …